Procter & Gamble: long-running sell signal, but strength is nearly spent
Sell signal at week 11 on Procter & Gamble: strength at 25 out of 100 and fading, trading not recommended per our model. The weekly confirmation closes bearish, but the technical picture lacks conviction.
Pfizer at week 2 of observation: weak signal, trading not recommended
Pfizer is at week 2 of observation of a sell signal. Signal strength stands at 4 out of 100 and the technical picture does not confirm the direction: our model classifies trading as not recommended.
PepsiCo: sell signal unconfirmed, market in wait-and-see mode
PepsiCo carries a sell signal active for 11 weeks, yet 3 observation weeks closed sideways with no confirmation. Strength 42/100, trading not recommended per our model.
PG&E Corporation: fourth week of a sell signal, strength at lows
PG&E Corporation carries a sell signal into its 4th week with a strength of 2 out of 100, near the bottom of the US short ranking. Our model flags elevated risk: trading not recommended.
PBR: a weak sell signal in an energy sector still gaining ground
Petroleo Brasileiro receives a weekly sell signal in its first week, but strength is at the floor — 5 out of 100. Our model flags trading as not recommended: opening a position carries elevated risk in current conditions.
Near all-time highs with 2 targets already hit: the trade is maturing
Palo Alto Networks in its 5th week long: IQS Phase at 73 out of 100, signal strength at 70 out of 100, stop already at breakeven. 2 DL2 targets reached. First reduction window in 1 week.